• 85 Citations
  • 5 h-Index
20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

I obtained my BSc (Hons) Biochemistry in 2002 and an MSc Biochemistry in 2005 at the University of Copenhagen, Denmark. After my training I was employed as a research assistant at Panum Institute with Prof. Sakari Kauppinen and as a result I obtained a great deal of experience in a number of techniques that are of great value, including print of LNA microarrays, hybridization of microRNA samples to LNA microarrays, scanning, analysis of the results, and real time PCR validation of microRNAs.

I successfully undertook and defended my PhD at the Department of Clinical Experimental Research at the Glostrup Research Institute (Glostrup University Hospital, Denmark) in March 2011. During my PhD I undertook studies using techniques such as wire myography, real time PCR, and immunohistochemistry. After my PhD I worked on an interim project in collaboration with Prof. Flemming Pociot in the same department at Glostrup Hopsital, investigating biomarkers of diabetes type I in children, employing real time PCR techniques to observe microRNA differential expression.

I am now employed at FRC ABES (Coventry University) as a Postdoctoral fellow in the research team of Profs Alfonso Jimenez and Helen Maddock, where I am assessing the effect of chemotherapy treatment-induced cardiotoxicity in vulnerable patient groups, such as children. Early assessment of cardiac injury and implementation of adjunct therapy options are explored in our diverse and dynamic team.

 

Research Interests

MicroRNA biomarkers ; Early detection of drug-induced cardiotoxicity ; Insulin resistance in women with Polycystic Ovarian Syndrome; Polycystic Ovarian Syndrome associated diabetes and cardiovascular diseases; Drug safety, validation and optimisation using in vitro disease models mimicking in vivo pathways

Vision Statement

 

Early detection of drug-induced cardiotoxicity is an important area of research, as reliable assessment method is still lacking specificity and sensitivity. A translational pre-clinical to clinical project including the latest molecular biology and genomic assays, including microRNA expression profiling, will aim to determine the feasibility of using a variety of biochemical and genomic microRNA biomarkers to help determine subclinical cardiac dysfunction in patients treated with chemotherapy. The intracellular pathways linked to cardiac injury develoment are unraveled and adjunct therapy options are explored. The research projects are instinctive progression of my current research expertise, combining genomic and molecular biology techniques to determine the complex links between drug safety interactions and pathophysiological disease conditions.

Education/Academic qualification

Degree, University of Copenhagen

1 Jan 200811 Mar 2011

MSc, University of Copenhagen

1 Aug 199930 Sep 2005

MBA, Niels Brock Copenhagen Business College

1 Jul 19991 Aug 1998

Keywords

  • RM Therapeutics. Pharmacology
  • cardiovascular diseases
  • microRNA
  • adjunct therapy
  • biomarker
  • RC0254 Neoplasms. Tumors. Oncology (including Cancer)
  • cancer
  • RG Gynecology and obstetrics
  • polycystic ovarian syndrome
  • insulin resistance
  • RZ Other systems of medicine
  • organ culture

Fingerprint Dive into the research topics where Hardip Sandhu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Research Output

  • 85 Citations
  • 5 h-Index
  • 10 Article

Ageing alters the severity of Sunitinib-induced cardiotoxicity: Investigating the mitogen activated kinase kinase 7 pathway association

Cooper, S., Sandhu, H., Hussain, A., Mee, C. & Maddock, H., 1 Jan 2019, In : Toxicology. 411, p. 49-59 11 p.

Research output: Contribution to journalArticle

Open Access
File
  • 1 Citation (Scopus)
    7 Downloads (Pure)

    Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity

    Sandhu, H., Cooper, S., Hussain, A., Mee, C. & Maddock, H., 1 Feb 2018, In : Toxicology. 394, p. 72-83

    Research output: Contribution to journalArticle

    Open Access
    File
  • 5 Citations (Scopus)
    26 Downloads (Pure)

    Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation

    Sandhu, H., Cooper, S., Hussain, A., Mee, C. & Maddock, H., 5 Nov 2017, In : European Journal of Pharmacology. 814, p. 95-105 11 p.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 6 Citations (Scopus)
    37 Downloads (Pure)
    Open Access
    File
  • 20 Downloads (Pure)

    Activities

    • 1 Editorial activity
    • 1 Visiting an external academic institution

    Clinics in Mother & Child Health (Journal)

    Hardip Sandhu (Editorial Board Member)
    1 Nov 2015

    Activity: Publication peer-review and editorial workEditorial activity

    Bablake School

    Hardip Sandhu (Supervisor)
    1 Oct 201530 Nov 2015

    Activity: Visiting an external institutionVisiting an external academic institution

    Prizes

    Annum Scholarship

    Hardip Sandhu (Recipient), 1 Jan 2008

    Prize: Prize (including medals and awards)

  • International Fellowship award

    Hardip Sandhu (Recipient), 1 Sep 2011

    Prize: Prize (including medals and awards)

    ISCBFM Young Investigators award

    Hardip Sandhu (Recipient), 1 Jun 2008

    Prize: Prize (including medals and awards)

  • Jr. Investigator Travel Award

    Hardip Sandhu (Recipient), 1 Sep 2013

    Prize: Prize (including medals and awards)

  • PhD stipend and scholarship

    Hardip Sandhu (Recipient), 1 Apr 2007

    Prize: Prize (including medals and awards)